CAP 150 (Capecitabine 150 mg)
Pill with imprint CAP 150 is Pink, Capsule-shape and has been identified as Capecitabine 150 mg. It is supplied by Shilpa Medicare Limited.
Capecitabine is used in the treatment of colorectal cancer; breast cancer, metastatic; breast cancer; anal cancer and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Capecitabine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for CAP 150
Capecitabine
- Imprint
- CAP 150
- Strength
- 150 mg
- Color
- Pink
- Size
- 11.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Antimetabolites
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Shilpa Medicare Limited
- National Drug Code (NDC)
- 63759-3000
- Inactive Ingredients
-
lactose anhydrous,
croscarmellose sodium,
hypromelloses,
microcrystalline cellulose,
magnesium stearate,
water,
titanium dioxide,
ferric oxide red,
ferric oxide yellow
Note: Inactive ingredients may vary.
More about capecitabine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 39 Reviews
- Drug class: antimetabolites
Consumer resources
- Other brands
- Xeloda
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.